TrialOrphanet journal of rare diseases2018

Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study.

Nicola Longo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.